Robert Klupacs
CHIEF EXECUTIVE OFFICER AND MANAGING DIRECTOR
Board of Director
BIO GENE TECHNOLOGY
Australia
Biography
Mr Klupacs is a highly experienced professional uniquely experienced in translating and commercialising early stage intellectual property from a variety of technology areas into commercial product or investable corporate vehicles. He is an Australian registered patent attorney who has had a wide and successful career to date within both private and publically traded companies as well as the academic arena. He has over 30 year’s corporate experience in the international technology development arena.He has focused primarily on biotechnology and biotechnology corporate development, particularly healthcare related, but has also been involved in the commercialisation of software, scientific instrumentation, food technologies and enabling agricultural technology. He has deep expertise and experience in all facets of corporate development and technology transfer including: IP licensing, patenting, intellectual property strategy and management, joint venture creation and management, fund-raising (private and public markets), corporate and scientific due diligence, technology and corporate acquisitions, corporate compliance and corporate governance and academic liaison. He is the Founder of 17 companies in Australia and Singapore.He is a highly experienced professional Director having been an Executive or Non-Executive Chairman/Director on over 21 different corporate entities. He was previously a member of the Pharmaceutical Industry Group and is currently a member of the Victorian Biotechnology Advisory Committee. He has also been involved as a director or advisor to a number of Australian companies and Co-Operative Research Centres. He is scientifically trained in pharmacology and biochemistry and has a deep understanding of molecular biology, genetics, bioinformatics, immunology, ophthalmology (device and therapeutic), neurosciences, oncology, reproductive biology and stem cell biology. Robert was Managing Director and CEO of ASX listed Circadian Technologies Pvt Ltd from 2008-2013.
Research Interest
Molecular Biology, Immunology, Bioinformatics
